Patent nad zdravili iz konoplje

Vsaj od leta 1974 je kristalno jasno da konoplja zdravi raka.

Oglejte si morje študij ki to potrjujejo.

In seveda patente na temo konoplje in kaj v njih piše.

In kdo si jih lasti.

SINCE 1974 THE GOVERNMENT HAVE KNOWN THAT THE CHEMICALS FOUND IN THE CANNABIS PLANT CAN BE USED TO TREAT CANCER!!!

PLEASE LOOK BELOW FOR A LOT OF REVIEWED STUDIES FROM AROUND THE GLOBE WHICH CONFIRM THESE FINDINGS!!!

These same chemicals can have a unique effect on each vital organ, homeostatically and holistically aiding them in their roles. This includes the kidneys and the nephrological system.

Many scientific studies have reported that various cannabinoids (both natural and synthetic) exert a wide range of growth-inhibiting effects on cancer cells, including:

- Triggering cell death, through a mechanism called apoptosis.

- Stopping cells from dividing.

- Preventing new blood vessels from growing into tumours –a process termed angiogenesis.

- Reducing the chances of cancer cells to metastasize through the body, by stopping cells from moving or invading neighbouring tissue.

- Speeding up the cell’s internal ‘waste disposal machine’ –a process known as autophagy – which can lead to cell death.

Please Share

All the US patents on cannabinoids that proves cannabis is a safe effective medicine.

http://www.cannabisinternational.org/patents.php

US Patent 4837228

Cannabichromene (CBC)

http://www.google.com/patents/US4837228

US Patent 4189491

Glaucoma Treatment

glavkom

http://www.google.com/patents/US4189491

US Patent 5631297

Anandamide Compounds

http://www.google.com/patents/US5631297

US Patent 6132762

Pain, inflammation and arthritis

Bolečine , vnetja in artritis

http://www.google.com/patents/US6132762

US Patent 6410588

Cannabidiol and inflammatory diseases

Kanabidiol in vnetne bolezni (CBD)

http://www.google.com/patents/US6410588

US Patent 6974568

Treatment for coughs

kašelj

http://www.google.com/patents/US6974568

US Patent 6630507

Inflammatory and autoimmune diseases

Strokes, Alzheimer’s and Parkinson’s

Vnetne in avtoimunske bolezni

Kapi, Alzheimerjeva in Parkinsonova

http://www.google.com/patents/US6630507

US Patent 7741365

Novel polycyclic cannabinoid analogs

http://www.google.com/patents/US7741365

US Patent 7597910

Prostate cancer and prostatitis

Rak prostate in prostatitis

http://www.google.com/patents/US7597910

US Patent 7977107

Detecting traces of cannabinoids

Odkrivanje sledov kanabinoidov

http://www.google.com/patents/US7977107

US Patent 8071641

Diabetes and insulitis

Diabetes in insulitis

http://www.google.com/patents/US8071641

US Patent 8242178

Cannabidiol and autoimmune hepatitis

Kanabidiol in avtoimunski hepatitis

http://www.google.com/patents/US8242178

US Patent 8034843

Nausea, vomiting and motion sickness

Slabost, bruhanje in potovalna bolezen

http://www.google.com/patents/US8034843

New Cannabis vs. Cancer Patent Sought

http://www.naturalblaze.com/…/new-can...patent-so…

All Languages listed-International Association for Cannabis as Medicine

English-International Association for Cannabis as Medicine

http://cannabis-med.org/index.php…

Deutsch

http://cannabis-med.org/index.php?lng=de

Français

http://cannabis-med.org/index.php?lng=fr

Nederlands

http://cannabis-med.org/index.php?lng=nl

Espanol

http://cannabis-med.org/index.php?lng=es

Portugues

http://cannabis-med.org/index.php?lng=po

Italiano

http://cannabis-med.org/index.php?lng=it

PEER REVIEWED SCIENTIFIC STUDIES REGARDING CANNABIS AND CANCER:

Recenzirane strokovne študije glede marihuane in RAKA :

Cannabinoid receptor systems: therapeutic targets for tumour intervention. UK

Sistemi Kanabinoidnih receptorjev : terapevtski cilji za intervencijo tumorja.

http://www.ncbi.nlm.nih.gov/pubmed/14640910

High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells. UK

Visoke koncentracije kanabinoidov aktivirajo apoptozo človeških U373MG gliomom celic.

http://www.ncbi.nlm.nih.gov/pubmed/18615640

Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. UK

Agonisti receptorjev Kanabinoidov so mitohondrijski inhibitorji: enotna hipoteza o tem, kako kanabinoidi modulirajo delovanje mitohondrijev in povzročijo smrt celice.

http://www.ncbi.nlm.nih.gov/pubmed/17931597

The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. UK

Kanabinoid Delta (9 ) tetrahidrokanabinol zavira RAS-MAPK in PI3K-AKT preživetveno signalizacijo in inducira BAD-posredovano apoptozo pri rakavih celicah debelega črevesa.

http://www.ncbi.nlm.nih.gov/pubmed/17583570

Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. UK

S konopljo povzročena citotoksičnost v levkemičnih celičnih linijah: Vloga receptorjev kanabinoidnih in MAPK poti.

http://www.ncbi.nlm.nih.gov/pubmed/15454482

Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in Delta9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells. USA

Ciljanje kanabinoidnih receptorjev za zdravljenje levkemije: vloga presluha med zunanjo in notranjo potjo v Delta9-tetrahidrokanabinola (THC) inducirani apoptozi celic Jurkat.

http://www.ncbi.nlm.nih.gov/pubmed/15978942

The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. USA

Stopnja izraza CB1 in CB2 receptorjev določi njihovo učinkovitost pri induciranju apoptoze v astrocitomih.

http://www.ncbi.nlm.nih.gov/pubmed/20090845

Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression. USA

Kanabidiol inducirano apoptozo v človeške celice levkemije: Vloga kanabiola pri urejanju P22PHOX in Nox4 izražanja.

http://www.ncbi.nlm.nih.gov/pubmed/16754784

Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. USA

Kanabidiol krepi zaviralne učinke delta9-tetrahidrokanabinola pri širjenju in preživetju človeških glioblastom celic.

http://www.ncbi.nlm.nih.gov/pubmed/20053780

Cannabinoids and the immune system. USA

Kanabinoidi in imunski sistem.

http://www.ncbi.nlm.nih.gov/pubmed/11854771

Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. USA

Delta(9)-tetrahidrokanabinol inducirano apoptozo v timus in vranico kot mehanizem za imunosupresijo

http://www.ncbi.nlm.nih.gov/pubmed/12130702

Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. USA

Delta9-tetrahidrokanabinol inducirane apoptoze v Jurkat levkemičnih celicah T, ki je urejeno s prenosom Bad do mitohondrijev

http://www.ncbi.nlm.nih.gov/pubmed/16908594

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. USA

Kanabinoidno inducirana apoptoza v imunskih celicah, kot pot do imunosupresije.

http://www.ncbi.nlm.nih.gov/pubmed/19457575

Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. USA

(Sintetični Kanabinoidni receptor Agonisti)zavira rast tumorja in metastaz raka dojke.

http://www.ncbi.nlm.nih.gov/pubmed/19887554

Cannabinoids for cancer treatment: progress and promise. USA

Kanabinoidi za zdravljenje raka: napredek in obljube.

http://www.ncbi.nlm.nih.gov/pubmed/18199524

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. USA

Ciljanje CB2 kanabinoidnih receptorjev kot nova terapija za zdravljenje malignih limfoblastnih bolezni.

http://www.ncbi.nlm.nih.gov/pubmed/12091357

Cannabinoid receptor as a novel target for the treatment of prostate cancer. USA

Kanabinoidni receptor kot nov cilj za zdravljenje raka prostate.

http://www.ncbi.nlm.nih.gov/pubmed/15753356

In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas. USA

Učinki kanabinoidov na makromolekularni biosintezi na Lewis pljučnih karcinomih.

http://www.ncbi.nlm.nih.gov/pubmed/616322

Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. USA

Kanabidiol kot zaviralec id-1 izraženih genov v agresivnih celicah raka dojke.

http://www.ncbi.nlm.nih.gov/pubmed/18025276

Cannabinoids as novel anti-inflammatory drugs. USA

Kanabinoidi kot nova protivnetna zdravila.

http://www.ncbi.nlm.nih.gov/pubmed/20191092

De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. SPAIN

Novo sintetizirani ceramid je vključen v kanabinoidnio-inducirane apoptoze.

http://www.ncbi.nlm.nih.gov/pubmed/11903061

Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis. SPAIN

Amphiregulin je dejavnik za odpornost gliom celic na kanabinoidno inducirane apoptoze .

http://www.ncbi.nlm.nih.gov/pubmed/19229996

Cannabinoids and cell fate. SPAIN

Kanabinoidi in usoda celic.

http://www.ncbi.nlm.nih.gov/pubmed/12182964

Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. SPAIN

Delta9-tetrahidrokanabinol inducira apoptozo v človeški PC-3 celici prostate preko mehanizma, ki je neodvisen od receptorjev.

http://www.ncbi.nlm.nih.gov/pubmed/10570948

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. SPAIN

Delta9-tetrahidrokanabinol inducira apoptozo v C6 celicah glioma.

http://www.ncbi.nlm.nih.gov/pubmed/9771884

Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. SPAIN

Kanabinoidi zavirajo vdor glioma celic

http://www.ncbi.nlm.nih.gov/pubmed/18339876

Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. SPAIN

Kanabinoidi ščitijo astrocite iz Ceramidno-inducirane apoptoze

http://www.ncbi.nlm.nih.gov/pubmed/12133838

Hypothesis: cannabinoid therapy for the treatment of gliomas? SPAIN

Hipoteza: kanabinoidna terapija za zdravljenje gliomov?

http://www.ncbi.nlm.nih.gov/pubmed/15275820

Involvement of cannabinoids in cellular proliferation. SPAIN

Vključenost kanabinoidov v celično proliferacijo.

http://www.ncbi.nlm.nih.gov/pubmed/15638794

Effects on cell viability. SPAIN

Vpliv na sposobnost preživetja celic.

http://www.ncbi.nlm.nih.gov/pubmed/16596790

Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. SPAIN

Kanabinoidno inducirana apoptoza pankreasnih tumorskih celic prek endoplazemskih retikulum genov povezanih s stresom.

http://www.ncbi.nlm.nih.gov/pubmed/16818650

Cannabinoids and gliomas. SPAIN

Kanabinoidi in gliomi.

http://www.ncbi.nlm.nih.gov/pubmed/17952650

Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. SPAIN

Delta9-tetrahidrokanabinol zavira potek celičnega ciklusa v človeških celicah raka dojke s pomočjo regulacije Cdc2.

http://www.ncbi.nlm.nih.gov/pubmed/16818634

Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas. SPAIN

Nasprotne spremembe izražanja v kanabinoidnih CB1 in CB2 receptorjih v človeških gliomih.

http://www.ncbi.nlm.nih.gov/pubmed/20307616

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. SPAIN

Zaviranje rasti tumorjev kože ... z aktivacijo kanabinoidnih receptorjev.

http://www.ncbi.nlm.nih.gov/pubmed/12511587

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2. SPAIN

Inhibicija rasti človeškega tumorja prostate PC - 3 celic s kanabinoidi R ( + ) - Methanandamide in JWH - 015 : vključevanje CB2 .

http://www.ncbi.nlm.nih.gov/pubmed/19690545

Control of the cell survival/death decision by cannabinoids. SPAIN

http://www.ncbi.nlm.nih.gov/pubmed/11269508

The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. SPAIN

http://www.ncbi.nlm.nih.gov/pubmed/16616335

The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway. SPAIN

http://www.ncbi.nlm.nih.gov/pubmed/16624285

p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells. SPAIN

http://www.ncbi.nlm.nih.gov/pubmed/16139274

Cannabinoids and ceramide: two lipids acting hand-by-hand. SPAIN

http://www.ncbi.nlm.nih.gov/pubmed/15958274

Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development. SPAIN

http://www.ncbi.nlm.nih.gov/pubmed/16787257

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. SPAIN

http://www.ncbi.nlm.nih.gov/pubmed/10700234

Cannabinoid receptors as novel targets for the treatment of melanoma. SPAIN

http://www.ncbi.nlm.nih.gov/pubmed/17065222

JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. SPAIN

http://www.ncbi.nlm.nih.gov/pubmed/18454173

Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. SPAIN

http://www.ncbi.nlm.nih.gov/pubmed/19425170

Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis. SPAIN

http://www.ncbi.nlm.nih.gov/pubmed/17202146

Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity? SPAIN

http://www.ncbi.nlm.nih.gov/pubmed/17675107

Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/11106791

Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/18938775

Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/14617682

The endocannabinoid anandamide neither impairs in vitro T-cell function nor induces regulatory T-cell generation. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/19189659

Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/16500647

The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/19539619

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/16728591

Cannabinoids in intestinal inflammation and cancer. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/19442536

The endocannabinoid system as a target for the development of new drugs for cancer therapy. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/12723496

Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/19059457

Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review). ITALY

http://www.ncbi.nlm.nih.gov/pubmed/17342320

The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/16909207

Cannabinoids as potential new therapy for the treatment of gliomas. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/18088200

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/9653194

Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/10913156

Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/19047095

Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/18354058

A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/19189054

Endocannabinoids in the immune system and cancer. ITALY

http://www.ncbi.nlm.nih.gov/pubmed/12052046

R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway. GERMANY

http://www.ncbi.nlm.nih.gov/pubmed/19015962

Antitumorigenic effects of cannabinoids beyond apoptosis. GERMANY

http://www.ncbi.nlm.nih.gov/pubmed/19889794

Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells. GERMANY

http://www.ncbi.nlm.nih.gov/pubmed/15361550

Cannabinoid receptors in human astroglial tumors. GERMANY

http://www.ncbi.nlm.nih.gov/pubmed/16893424

Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. GERMANY

http://www.ncbi.nlm.nih.gov/pubmed/15026328

Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1. GERMANY

http://www.ncbi.nlm.nih.gov/pubmed/19914218

Pharmacokinetics and pharmacodynamics of cannabinoids. GERMANY

http://www.ncbi.nlm.nih.gov/pubmed/12648025

Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. ISRAEL

http://www.ncbi.nlm.nih.gov/pubmed/17934890

Cannabinoids and cancer. ISRAEL

http://www.ncbi.nlm.nih.gov/pubmed/16250836

Cannabinoids in health and disease. ISRAEL

http://www.ncbi.nlm.nih.gov/pubmed/18286801

A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells. ISRAEL

http://www.ncbi.nlm.nih.gov/pubmed/16571653

Gamma-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells. ISRAEL

http://www.ncbi.nlm.nih.gov/pubmed/14692532

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. ISRAEL

http://www.ncbi.nlm.nih.gov/pubmed/11586361

HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor. ISRAEL

http://www.ncbi.nlm.nih.gov/pubmed/17237277

Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans. SWITZERLAND

http://www.ncbi.nlm.nih.gov/pubmed/19480992

Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. SWITZERLAND

http://www.ncbi.nlm.nih.gov/pubmed/19509271

Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies? SWITZERLAND

http://www.ncbi.nlm.nih.gov/pubmed/19589225

Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. SWITZERLAND

http://www.ncbi.nlm.nih.gov/pubmed/15453094

Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation. SWEDEN

http://www.ncbi.nlm.nih.gov/pubmed/18546271

Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma. SWEDEN

http://www.ncbi.nlm.nih.gov/pubmed/16936228

Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma. SWEDEN

http://www.ncbi.nlm.nih.gov/pubmed/16337199

Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism. SWEDEN

http://www.ncbi.nlm.nih.gov/pubmed/19609004

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. HUNGARY

http://www.ncbi.nlm.nih.gov/pubmed/19608284

Pharmacological synergism between cannabinoids and pa*censored*axel in gastric cancer cell lines. JAPAN

http://www.ncbi.nlm.nih.gov/pubmed/19394652

Different views on the association between cannabinoids and cancer. SLOVAKIA

http://www.ncbi.nlm.nih.gov/pubmed/16835997

Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells. KOREA

http://www.ncbi.nlm.nih.gov/pubmed/20336665

Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma. SAUDI ARABIA

http://www.ncbi.nlm.nih.gov/pubmed/18197164

Cannabinoids in the treatment of cancer. NEW ZEALAND

http://www.ncbi.nlm.nih.gov/pubmed/19442435

Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein. POLAND

http://www.ncbi.nlm.nih.gov/pubmed/15451022

Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers? UKRAINE

http://www.ncbi.nlm.nih.gov/pubmed/18438336

A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells. TAIWAN

http://www.ncbi.nlm.nih.gov/pubmed/18387516

The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration. THAILAND

http://www.ncbi.nlm.nih.gov/pubmed/19916793

Konoplja zdravi, zato zaupaj naravi

p.s: ker mi ni vseeno kaj bo jutri - zu3 se na fu3